Skip to main content
VERICI DX PLC logo

VERICI DX PLC — Investor Relations & Filings

Ticker · VRCI ISIN · GB00BM8HZD43 LEI · 213800FI5WE4FVQ3G645 IL Real estate activities
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-07-28 Major Shareholding Noti…
Country GB United Kingdom
Listing IL VRCI

About VERICI DX PLC

https://www.vericidx.com/

Verici Dx is an immuno-diagnostics company developing and commercializing a suite of proprietary tests for the kidney transplant market. The company's platform utilizes artificial intelligence-assisted transcriptomic analysis of RNA signatures to provide data-driven insights to clinicians. These tests are designed to decipher the body's immune response and other biological signals, enabling personalized risk assessment for organ injury, rejection, and graft failure. The goal is to assist clinicians in medical management throughout the transplant process, from pre-transplant to late-stage care, ultimately aiming to improve patient outcomes and long-term graft survival.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in share ownership (crossing a threshold) by Canaccord Genuity Group Inc. in Verici Dx PLC. This type of regulatory filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided taxonomy.
2025-07-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the standard regulatory template used in the UK for disclosing significant changes in share ownership (major shareholding notifications). It explicitly identifies the issuer (Verici Dx PLC), the person subject to the notification (UBS Group AG), and the percentage of voting rights held. This fits the definition of a Major Shareholding Notification (MRQ).
2025-07-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing changes in significant share ownership. It explicitly details the issuer (Verici Dx PLC), the person subject to the notification (Maven Capital Partners UK LLP), and the change in voting rights percentage. This fits the definition of a Major Shareholding Notification (MRQ).
2025-07-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Verici Dx PLC. This form is specifically used to report changes in significant share ownership (crossing thresholds) as required by regulatory bodies. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-07-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross specific thresholds. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-07-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'Standard form for notification of major holdings' (TR-1 form) filed via the London Stock Exchange's RNS service. It details a change in shareholding by Pentwater Capital Management LP in Verici DX PLC, crossing a specific threshold. This falls directly under the definition of a Major Shareholding Notification.
2025-07-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.